Shingles Therapeutics Pipeline Market Insights Report 2024 Featuring Zhuhai Trinomab, Nobelpharma, Dynavax Technologies, Jiangsu Rec-Biotechnology, Moderna, Curevo, and Amytrx Therapeutics...
Dynavax Technologies Corporation (DVAX)
Last dynavax technologies corporation earnings: 3/11 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.dynavax.com
Company Research
Source: Yahoo! Finance
This "Shingles - Pipeline Insight, 2024" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Shingles pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. "Shingles- Pipeline Insight, 2024" report outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Shingles pipeline landscape is provided which includes the disease overview and Shingles treatment guidelines. The assessment part of the report embraces, in depth Shingles commercial assessment and clinical assessment of the pipeline products under development. In the report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any)
Show less
Read more
Impact Snapshot
Event Time:
DVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DVAX alerts
High impacting Dynavax Technologies Corporation news events
Weekly update
A roundup of the hottest topics
DVAX
News
- Dynavax Technologies: Slow And Steady Wins The Race [Seeking Alpha]Seeking Alpha
- Global Vaccine Adjuvants Market to Show Remarkable Growth at a CAGR of ~13% by 2030 | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Dynavax Technologies Corporation Just Recorded A 28% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]Yahoo! Finance
- Dynavax Technologies Co. (NASDAQ: DVAX) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $20.00 to $15.00. They now have a "neutral" rating on the stock.MarketBeat
- Dynavax Technologies Co. (NASDAQ: DVAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $29.00 price target on the stock.MarketBeat
DVAX
Earnings
- 8/6/24 - Beat
DVAX
Sec Filings
- 9/16/24 - Form SC
- 9/9/24 - Form SC
- 8/6/24 - Form S-8
- DVAX's page on the SEC website